Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 13
Item hits:
Issue DateTitleAuthor(s)
11-Jun-2014Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cellsLombardo, Y; Faronato, M; Filipovic, A; Vircillo, V; Magnani, L, et al
1-Jul-2016Going off the grid: ERα breast cancer beyond estradiolPerone, Y; Magnani, L; Cancer Research UK
10-May-2018TGF-ß induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionOttaviani, S; Stebbing, J; Frampton, A; Zagorac, S; Krell, J, et al
9-May-2019SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancerPerone, Y; Farrugia, AJ; Meira, AR; Győrffy, B; Ion, C, et al
17-Oct-2016Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancerHarrod, A; Fulton, J; Nguyen, VTM; Periyasamy, M; Ramos Garcia, L, et al
27-Nov-2015Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionNguyen, VTM; Barozzi, I; Faronato, M; Lombardo, Y; Steel, JH, et al
4-Aug-2015LMTK3 represses tumor suppressor-like genes through chromatin remodeling in breast cancerXu, Y; Zhang, H; Van, TMN; Angelopoulos, N; Nunes, J, et al
14-Jun-2016CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancerPatel, H; Abduljabbar, R; Lai, CF; Periyasamy, M; Harrod, A, et al
14-Jun-2016Expression of CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor positive breast cancerPatel, H; Abduljabbar, R; Chun-Fui, L; Periyasamy, M; Harrod, A, et al
4-May-2018Extensive and systematic rewiring of histone post-translational modifications in cancer model systemsNoberini, R; Osti, D; Miccolo, C; Richichi, C; Lupia, M, et al